About
Philip Katz advises pharmaceutical and biotechnology companies on U.S. FDA regulatory matters, including product development, approval, lifecycle management, compliance, and advocacy before federal agencies and courts. He heads the firm's Pharma/Biotech practice group.
Practice areas
FDA RegulatoryPharmaceuticals & BiotechnologyLife SciencesRegulatory ComplianceLitigation
Office
Expertise
Hatch-Waxman ActOrphan Drug ActBiosimilarsFDA EnforcementProduct Lifecycle Management
Education
- J.D., Georgetown University Law Center, magna cum laude, Order of the Coif, 1992
- B.A., University of Virginia, with distinction, 1981
Languages
English